2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)

摘要 行政核心的使命是促进能力建设和培训的使命 加州大学滨江（UCR）- City of Hope综合癌症中心（CoH-CCC）P20 程序. UCR和CoH-CCC都致力于为P20 PI和研究者提供必要的 资源，包括受保护的时间和文书援助。行政核心将提供科学的 领导、行政和财务管理。核心将由P20 PI的Ernest Martinez博士领导。 (UCR)和医学博士维多利亚西瓦尔特。（CoH）. P20 PI都是R 01资助的，并致力于培训 代表性不足的少数民族。 外部咨询委员会（EAB）和内部咨询委员会（IAB）将帮助指导我们的P20规划， 执行和评价。我们将共同制定初步计划，确定优先事项，并实施和 评估我们是否实现了P20目标和里程碑。 我们的EAB领导人非常有资格指导我们的P20伙伴关系。EAB成员是世界领先的 健康科学的差距，并导致自己的P20和U 54赠款。EAB成员包括：Elana Martinez博士(UC San Diego），Lucio Miele，M.D. (LSU)理查德·理查森博士（NCCU）和罗伯特 Winn，医学博士（伊利诺伊大学，芝加哥）。EAB领导人将每年在现场开会，评估 P20。 我们的IAB成员是UCR和CoH-CCC的高级领导人。UCR IAB成员包括：博士。 Kelechi Kalu博士，副教务长和政治学教授和弗朗西斯·斯莱德克博士，细胞教授 生物学和毒理学。CoH-CCC IAB领导人包括大卫霍恩博士，CoH-CCC开发 治疗项目和贝克曼治疗总监和琳达马尔卡斯博士，院长翻译 科学和对外事务CoH-CCC和董事会加州干细胞转化研究 程序. IAB和P20领导人将每季度举行一次会议，如果需要，可以更频繁地举行会议，以提供战略方向， 政策制定和评估我们的P20伙伴关系项目。

ABSTRACT The mission of the Administrative Core is to facilitate the capacity building and training mission of the University of California Riverside (UCR) - City of Hope Comprehensive Cancer Center (CoH-CCC) P20 Program. Both UCR and CoH-CCC are committed to providing the P20 PIs and investigators with necessary resources including protected time and clerical assistance. The Administrative Core will provide scientific leadership, administration, and fiscal management. The Core will be led by P20 PI's, Ernest Martinez, Ph.D. (UCR) and Victoria Seewaldt, M.D. (CoH). The P20 PI's are both R01 funded and are committed to training of underrepresented minorities. External Advisory Board (EAB) and Internal Advisory Board (IAB) will help guide our P20 planning, implementation, and evaluation. Together, we will develop initial plans, set priorities, and implement and evaluate whether we meet our P20 goals and milestones. Our EAB leaders are well-qualified to guide our P20 Partnership. EAB members are world leaders in the health science of disparities and lead their own P20 and U54 grants. EAB members include: Elana Martinez, Ph.D. (UC San Diego), Lucio Miele, M.D. (LSU), Ricardo Richardson, Ph.D. (NCCU), and Robert Winn, M.D. (University of Illinois, Chicago). EAB leaders will meet on site yearly to evaluate progress of the P20. Our IAB members are senior leaders within UCR and CoH-CCC. UCR IAB members include: Dr. Kelechi Kalu, Ph.D., Vice Provost and Professor of Political Science and Dr. Frances Sladek, Professor of Cell Biology and Toxicology. CoH-CCC IAB leaders include David Horne, Ph.D., CoH-CCC Developmental Therapeutics Program and Beckman Therapeutic Director and Linda Malkas, Ph.D., Dean of Translational Science and External Affairs CoH-CCC and Board of Directors California Stem Cell Translational Research Program. IAB and P20 leaders will meet quarterly, or more frequently if needed, to provide strategic direction, policy development, and evaluation of our P20 Partnership Project.